Paper Details

  1. Home
  2. Paper Details

Evaluation of the safety and efficacy of bupropion in depression.

Author: HalarisA E, RenoR M, SternW C, Van Wyck FleetJ

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Bupropion (300 or 450 mg/day) was more effective than placebo in treating depression in 30 hospitalized patients. The 300 mg dose showed a significant antidepressant effect compared to placebo.
Paper Details　
Original Abstract of the Article :
A placebo-controlled double-blind study was conducted to test the antidepressant effects of bupropion at dosage levels of 300 or 450 mg/day. Subjects were 30 hospitalized primary major depressives who were treated for 4 weeks. Physical and behavioral measures were obtained at baseline and at the end...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6406435

データ提供：米国国立医学図書館（NLM）

Bupropion - A Potential Antidepressant

The desert of depression research is vast and complex, with scientists constantly seeking new and effective treatments for this debilitating condition. This study explores the efficacy and safety of bupropion, a medication with potential antidepressant properties. The authors conduct a placebo-controlled double-blind study involving hospitalized individuals with major depression, evaluating the effects of bupropion at different dosages. Their findings suggest that bupropion, particularly at a dosage of 300 mg/day, shows promise in reducing symptoms of depression and anxiety. This research provides valuable insights into the potential of bupropion as a therapeutic option for depression.

Bupropion's Potential for Depression Treatment

This study offers promising evidence for the potential of bupropion as an effective treatment for depression, particularly at a dosage of 300 mg/day. While further research is needed to confirm its efficacy and determine optimal dosing strategies, this research provides a valuable starting point for exploring bupropion's role in depression treatment. This research is like finding a hidden oasis in the desert, offering hope for a new and potentially effective treatment option.

The Importance of Research in Depression Treatment

This study underscores the importance of ongoing research in the pursuit of effective treatments for depression. Just as a camel relies on its instincts and knowledge to navigate the desert, we must rely on scientific research to guide our path toward better understanding and treating this complex condition. This research highlights the need for rigorous scientific inquiry and a commitment to finding new and innovative solutions for those struggling with depression.

Dr.Camel's Conclusion

This study provides valuable insights into the potential of bupropion as an antidepressant, offering a glimmer of hope for those seeking effective treatment options. The desert of depression research is vast and complex, but with continued research and a commitment to improving the lives of those affected by this condition, we can find new and innovative solutions.

Date :
  1. Date Completed 1983-07-08
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

6406435

DOI: Digital Object Identifier

6406435

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.